Skip to the page

Data / Form D filings / ClearNote Health, Inc.

ClearNote Health, Inc.: Form D filings

ClearNote Health, Inc., a biotechnology company in San Diego, CA, filed 2 Form D notices with the SEC between 2021 and 2025. The latest, on June 5, 2025, reports $21.8 million sold of a $60.5 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10578 SCIENCE CENTER DRIVE, SUITE 210, San Diego, CA, 92121
Phone
(833) 258-7827
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1865556

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 5, 2025New notice$60,534,812$21,784,827$38,749,9855May 27, 2025sec.gov
Jun 21, 2021New notice$71,621,122$69,321,211$2,299,91114Mar 20, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Tina Mattias NovaDirector
David MullarkeyExecutive Officer, Director
Samuel Mattias LevyExecutive Officer
Johan Mattias WestmanDirector
Stephen QuakeDirector

Other biotechnology companies in California that filed recently

Every Form D from the week of Jun 2, 2025 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ClearNote Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.